Platelet glycoprotein IIb/IIIa inhibitors in acute ischemic stroke

Neurology India

Volumn 56, Issue 4, 2008, Pages 399-404

  Kumar, Sudhir ^a,b   Rajshekher, G ^a   Prabhakar, Subhashini ^a  

^a APOLLO HOSPITAL   (India)

^b APOLLO HOSPITALS   (India)

Author keywords

Abciximab; Acute ischemic stroke; Cerebrovascular disease; Platelet glycoprotein IIb IIIa inhibitors; Tirofiban

Indexed keywords

ABCIXIMAB; ALTEPLASE; FIBRINOGEN RECEPTOR; HEPARIN; PLACEBO; TIROFIBAN; UROKINASE; VITRONECTIN RECEPTOR;

ACUTE CORONARY SYNDROME; BLEEDING; BRAIN EMBOLISM; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; DRUG FATALITY; DRUG RECEPTOR BINDING; DRUG SAFETY; FIBRINOLYTIC THERAPY; HUMAN; LOW DRUG DOSE; MIDDLE CEREBRAL ARTERY OCCLUSION; MONOTHERAPY; MORTALITY; NEUROSURGERY; OCCLUSIVE CEREBROVASCULAR DISEASE; RANDOMIZED CONTROLLED TRIAL; RECANALIZATION; REVIEW; SUBARACHNOID HEMORRHAGE; THROMBOCYTE AGGREGATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VERTEBROBASILAR INSUFFICIENCY;

ACUTE DISEASE; BRAIN ISCHEMIA; FIBRINOLYTIC AGENTS; HUMANS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; STROKE;

EID: 58749107885     PISSN: 00283886     EISSN: 19984022     Source Type: Journal    
DOI: 10.4103/0028-3886.44571     Document Type: Review

References (29)

1. Anand K, Chowdhury D, Singh KB, Pandav CS, Kapoor SK. Estimation of mortality and morbidity due to strokes in India. Neuroepidemiology 2001;20:208-11.
2. Durai Pandian J, Padma V, Vijaya P, Sylaja PN, Murthy JM. Stroke and thrombolysis in developing countries. Int J Stroke 2007;2:17-26.
3. Yamanouchi H, Shimada H, Kuramoto K. Subtypes and proportions of cerebrovascular disease in an autopsy series in a Japanese geriatric hospital. Klin Wochenschr 1990;68:1173-7.
4. Schellinger PD, Fiebach JB, Mohr A, Ringleb PA, Jansen O, Hacke W. Thrombolytic therapy for ischemic stroke: A review, Part I - Intravenous thrombolysis. Crit Care Med 2001;29:1812-8.
5. Suwanwela NC, Phanthumchinda K, Likitjaroen Y. Thrombolytic therapy in acute ischemic stroke in Asia: The first prospective evaluation. Clin Neurol Neurosurg 2006;108:549-52.
6. Nandigam K, Narayan SK, Elangovan S, Dutta TK, Sethuraman KR, Das AK. Feasibility of acute thrombolytic therapy for stroke. Neurol India 2003;51:470-3.
7. Neki NS. Platelet glycoprotein IIb/IIIa receptor inhibitors-role in coronary artery disease. J Indian Acad Community Med 2004;5:259-65.
8. Brener SJ, Barr LA, Burchenal JE, Katz S, George BS, Jones AA, et al. Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. Circulation 1998;98:734-41.
9. The PURSUIT Trial Investigators. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. N Engl J Med 1998; 339:436-43.
10. The Abciximab in Ischemic Stroke Investigators. Abciximab in acute ischemic stroke: A randomized, double-blind, placebo-controlled, dose-escalation study. Stroke 2000;31:601-9.
11. Mitsias PD, Lu M, Silver B, Morris D, Ewing JR, Daley S, et al. MRI-guided, open trial of abciximab for ischemic stroke within a 3- to 24-hour window. Neurology 2005;65:612-5.
12. Mandava P, Anderson JA, Kent TA. MRI-guided, open trial of abciximab for ischemic stroke within a 3- to 24-hour window. Neurology 2006;66:1132.
13. Morris DC, Silver B, Mitsias P, Lewandowski C, Patel S, Daley S, et al. Treatment of acute stroke with recombinant tissue plasminogen activator and abciximab. Acad Emerg Med 2003;10:1396-9.
14. Eckert B, Koch C, Thomalla G, Kucinski T, Grzyska U, Roether J, et al. Aggressive therapy with intravenous abciximab and intra-arterial rtPA and additional PTA/stenting improves clinical outcome in acute vertebrobasilar occlusion: Combined local fibrinolysis and intravenous abciximab in acute vertebrobasilar stroke treatment (FAST): Results of a multicenter study. Stroke 2005;36:1160-5.
15. Heo JH, Lee KY, Kim SH, Kim DI. Immediate reocclusion following a successful thrombolysis in acute stroke: A pilot study. Neurology 2003;60:1684-7.
16. Velat GJ, Burry MV, Eskioglu E, Dettorre RR, Firment CS, Mericle RA. The use of abciximab in the treatment of acute cerebral thromboembolic events during neuroendovascular procedures. Surg Neurol 2006;65:352-8, discussion 358-9.
17. Wholey MH, Wholey MH, Eles G, Toursakissian B, Bailey S, Jarmolowski C, et al. Evaluation of glycoprotein IIb/IIIa inhibitors in carotid angioplasty and stenting. J Endovasc Ther 2003;10:33-41.
18. Abciximab Emergent Stroke Treatment Trial (AbESTT) Investigators. Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of a randomized phase 2 trial. Stroke 2005;36:880-90.
19. Adams HP Jr, Effron MB, Torner J, Frayne J, Teal P, Leclerc J, et al. Emergency administration of abciximab for treatment of patients with acute ischemic stroke: Results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II). Stroke 2008;39:87-99.
20. Junghans U, Seitz RJ, Aulich A, Freund HJ, Siebler M. Bleeding risk of tirofiban: A nonpeptide GPIIb/IIIa platelet receptor antagonist in progressive stroke: An open pilot study. Cerebrovasc Dis 2001;12:308-12.
21. Straub S, Junghans U, Jovanovic V, Wittsack HJ, Seitz RJ, Siebler M. Systemic thrombolysis with recombinant tissue plasminogen activator and tirofiban in acute middle cerebral artery occlusion. Stroke 2004;35:705-9.
22. Seitz RJ, Hamzavi M, Junghans U, Ringleb PA, Schranz C, Siebler M. Thrombolysis with recombinant tissue plasminogen activator and tirofiban in stroke: Preliminary observations. Stroke 2003;34:1932-5.
23. Mangiafico S, Cellerini M, Nencini P, Gensini G, Inzitari D. Intravenous glycoprotein IIb/IIIa inhibitor (tirofiban) followed by intra-arterial urokinase and mechanical thrombolysis in stroke. AJNR Am J Neuroradiol 2005;26:2595-601.
24. Liebeskind DS, Pollard JR, Schwartz ED, Cucchiara BL, McGarvey ML, Hurst RW. Vertebrobasilar thrombolysis with intravenous tirofiban: Case report. J Thromb Thrombolysis 2002;13:81-4.
25. Junghans U, Seitz RJ, Wittsack HJ, Aulich A, Siebler M. Treatment of acute basilar artery thrombosis with a combination of systemic alteplase and tirofiban, a nonpeptide platelet glycoprotein IIb/IIIa inhibitor: Report of four cases. Radiology 2001;221:795-801.
26. Junghans U, Seitz RJ, Ritzl A, Wittsack HJ, Fink GR, Freund HJ, et al. Ischemic brain tissue salvaged from infarction by the GP IIb/IIIa platelet antagonist tirofiban. Neurology 2002;58:474-6.
27. Seitz RJ, Meisel S, Moll M, Wittsack HJ, Junghans U, Siebler M. The effect of combined thrombolysis with rtPA and tirofiban on ischemic brain lesions. Neurology 2004;62:2110-2.
28. Junghans U, Siebler M. Cerebral microembolism is blocked by tirofiban: A selective nonpeptide platelet glycoprotein IIb/IIIa receptor antagonist. Circulation 2003;107:2717-21.
29. Available from: http://www.docguide.com/news/content.nsf/news/ 852571020057CCF685257178005861A6. [last accessed on 2008 Jun 7].